Drugs / BAT4306F
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04152148 | Sep 2018 → Jan 2021 | B-cell non-Hodgkin lymphoma | Bio-Thera Solutions | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BAT4306F | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04152148 ↗ |